- Argument1 of 2›
Advertising prescription drugs in media trivializes their potential harm
If a medication with potentially deadly side effects is advertised in the same commercial break as a new candy, car insurance, or perhaps even children’s show, it implies that utilizing potentially harmful medications is as mundane and accessible as buying a six-pack at the store.
The argument
Advertising is created for the purpose of selling a product. The idea that DTC (direct-to-consumer) advertising of prescription drugs is about anything other than sales is absolutely preposterous. DTC did not begin until the 1980s, and has since become a multibillion dollar industry that profits off of convincing people they may or may not need them. When drug commercials are shown along with car, yogurt, and various other product commercials, it commodifies them, turning them into just any other solution to your problems -- like that new car will make you happier, and that yogurt will make you slimmer. Prescription medications require a prescription for a reason; they can have seriously harmful side effects that need to be discussed with and evaluated by a healthcare provider. To advertise them as a quick and easy purchase is dangerous to the well-being of all.
Premises
Counter-arguments
Just because something is advertised, doesn’t inherently make it bad or insidious. DTC works to aid consumers in learning about new medications that might help them with potential health conditions and to be able to discuss them as potential options with their healthcare provider. DTC equips patients to ask questions; it is not a mandate for patients to blindly consume medications.
Rejecting the premises
[Rejecting P1] That advertising exists to sell is true and does not settle the question, since advertising that sells can also inform. The premise treats a commercial motive as though it determined the effect, and the industry's size measures spending rather than harm. [Rejecting P2] The commodification claim is an aesthetic observation presented as evidence. Adjacency in a commercial break is a scheduling fact, and the argument needs a demonstration that viewers actually come to treat medicines as ordinary consumer goods, not an assertion that the format implies they will. [Rejecting P3] This is the strongest premise and it does not deliver the conclusion, because a prescriber still stands between the advertisement and the drug. The serious case against the practice runs through evidence the argument never uses — that advertising shifts prescribing toward newer and costlier drugs with shorter safety records, that patient requests raise prescribing rates, and that only two countries permit it at all — and it would still have to answer the counter's point that some campaigns bring undiagnosed patients into treatment.